| Q37589815 | A DNA segment spanning the mouse Tnfsf11 transcription unit and its upstream regulatory domain rescues the pleiotropic biologic phenotype of the RANKL null mouse |
| Q41017658 | A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro |
| Q90190614 | A Review of the Potential Application of Osteocyte-Related Biomarkers, Fibroblast Growth Factor-23, Sclerostin, and Dickkopf-1 in Predicting Osteoporosis and Fractures |
| Q34802787 | A method for isolating high quality RNA from mouse cortical and cancellous bone |
| Q34658332 | A new method to investigate how mechanical loading of osteocytes controls osteoblasts |
| Q49925395 | A vitronectin-derived peptide reverses ovariectomy-induced bone loss via regulation of osteoblast and osteoclast differentiation. |
| Q40012509 | AAV8-mediated expression of N-acetylglucosamine-1-phosphate transferase attenuates bone loss in a mouse model of mucolipidosis II. |
| Q39448176 | Absence of the Vitamin D Receptor Inhibits Atherosclerotic Plaque Calcification in Female Hypercholesterolemic Mice |
| Q92282155 | Actin and Actin-Associated Proteins in Extracellular Vesicles Shed by Osteoclasts |
| Q35586060 | Activation of HIFa pathway in mature osteoblasts disrupts the integrity of the osteocyte/canalicular network |
| Q53190419 | Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG. |
| Q36005508 | Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations |
| Q27342550 | Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures |
| Q36733053 | Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts |
| Q38047183 | Advances in osteoimmunology: pathophysiologic concepts and treatment opportunities |
| Q64889366 | Ageing characteristics of bone indicated by transcriptomic and exosomal proteomic analysis of cortical bone cells. |
| Q41917846 | Aging, Osteocytes, and Mechanotransduction. |
| Q93208366 | Alterations in osteocyte mediated osteoclastogenesis during estrogen deficiency and under ROCK-II inhibition: An in vitro study using a novel postmenopausal multicellular niche model |
| Q36144039 | Alterations in the osteocyte lacunar-canalicular microenvironment due to estrogen deficiency |
| Q37609485 | Altered gene dosage confirms the genetic interaction between FIAT and αNAC. |
| Q38271156 | Alternative pathways of osteoclastogenesis in inflammatory arthritis |
| Q34647373 | An RNA-seq protocol to identify mRNA expression changes in mouse diaphyseal bone: applications in mice with bone property altering Lrp5 mutations |
| Q42038120 | Anabolic steroids reduce spinal cord injury-related bone loss in rats associated with increased Wnt signaling |
| Q50090300 | Autophagy as a target for glucocorticoid-induced osteoporosis therapy |
| Q53162347 | Autophagy: a new player in skeletal maintenance? |
| Q37133071 | Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner |
| Q37189212 | Basic biology of skeletal aging: role of stress response pathways |
| Q28265584 | Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab |
| Q50101275 | Biology and Mechanisms of Action of the Vitamin D Hormone |
| Q26801599 | Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells |
| Q34366449 | Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond |
| Q34646678 | Biomechanical forces in the skeleton and their relevance to bone metastasis: biology and engineering considerations. |
| Q35878832 | Bone Is a Major Target of PTH/PTHrP Receptor Signaling in Regulation of Fetal Blood Calcium Homeostasis. |
| Q38835028 | Bone Loss in HIV Infection |
| Q99561826 | Bone Marrow Microvasculature |
| Q40067457 | Bone Remodeling and the Microbiome. |
| Q47859307 | Bone Resorption Is Regulated by Circadian Clock in Osteoblasts |
| Q38185586 | Bone and the innate immune system |
| Q27023494 | Bone cell communication factors and Semaphorins |
| Q38185298 | Bone cell senescence: mechanisms and perspectives |
| Q42266513 | Bone corticalization requires local SOCS3 activity and is promoted by androgen action via interleukin-6. |
| Q35964838 | Bone loss following spinal cord injury in a rat model. |
| Q39093915 | Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression. |
| Q48361504 | Bone mechanobiology in mice: toward single-cell in vivo mechanomics |
| Q37415673 | Bone morphogenetic proteins signal via SMAD and mitogen-activated protein (MAP) kinase pathways at distinct times during osteoclastogenesis |
| Q64066842 | Bone morphogenetic proteins: Their role in regulating osteoclast differentiation |
| Q48003981 | Bone remodeling as a spatial evolutionary game |
| Q26797366 | Bone remodeling in the context of cellular and systemic regulation: the role of osteocytes and the nervous system |
| Q37976305 | Bone, sweet bone--osteoporotic fractures in diabetes mellitus. |
| Q85075751 | Bone: Osteocyte RANKL in bone homeostasis: a paradigm shift? |
| Q98771616 | Bovine Milk Extracellular Vesicles Are Osteoprotective by Increasing Osteocyte Numbers and Targeting RANKL/OPG System in Experimental Models of Bone Loss |
| Q97527734 | CSF-1 in Osteocytes Inhibits Nox4-mediated Oxidative Stress and Promotes Normal Bone Homeostasis |
| Q30538292 | Calcium influx through L-type CaV1.2 Ca2+ channels regulates mandibular development |
| Q26775406 | Caldecrin: A pancreas-derived hypocalcemic factor, regulates osteoclast formation and function |
| Q28072561 | Cancer Cell Colonisation in the Bone Microenvironment |
| Q36480304 | Canonical Notch activation in osteocytes causes osteopetrosis |
| Q45942621 | Carbonic anhydrase III protects osteocytes from oxidative stress. |
| Q33831453 | Carboxyl terminus of Hsp70-interacting protein regulation of osteoclast formation in mice through promotion of tumor necrosis factor receptor-associated factor 6 protein degradation |
| Q26865580 | Cartilage to bone transitions in health and disease |
| Q92185702 | Cathepsin K-deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression |
| Q28067045 | Cell Death in Chondrocytes, Osteoblasts, and Osteocytes |
| Q38934459 | Cell-to-cell communication in guided bone regeneration: molecular and cellular mechanisms |
| Q38960505 | Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk |
| Q26748812 | Characterisation of matrix vesicles in skeletal and soft tissue mineralisation |
| Q41972888 | Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model |
| Q51216875 | Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone. |
| Q26743435 | Clinical applications of vibration therapy in orthopaedic practice |
| Q92370299 | Conditional deletion of E11/Podoplanin in bone protects against ovariectomy-induced increases in osteoclast formation and activity |
| Q92221417 | Conditional deletion of E11/podoplanin in bone protects against load-induced osteoarthritis |
| Q41261207 | Conditioned medium from fresh and demineralized bone enhances osteoclastogenesis in murine bone marrow cultures |
| Q35096932 | Connexin 43 channels are essential for normal bone structure and osteocyte viability |
| Q35781909 | Connexin 43 deficiency desensitizes bone to the effects of mechanical unloading through modulation of both arms of bone remodeling |
| Q42500075 | Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor |
| Q37445916 | Control of bone remodeling by the peripheral sympathetic nervous system |
| Q35991486 | Control of bone resorption in mice by Schnurri-3. |
| Q36822669 | Coordinated transcriptional regulation of bone homeostasis by Ebf1 and Zfp521 in both mesenchymal and hematopoietic lineages |
| Q60312831 | Cortical bone is an extraneuronal site of norepinephrine uptake in adult mice |
| Q42053319 | Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice |
| Q90263630 | Coupling factors involved in preserving bone balance |
| Q59051790 | Coupling of bone resorption and formation by RANKL reverse signalling |
| Q37506724 | Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit |
| Q47131626 | Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation |
| Q40988880 | DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age. |
| Q53208210 | Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone. |
| Q87327139 | Decreased activity of osteocyte autophagy with aging may contribute to the bone loss in senile population |
| Q37557163 | Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II. |
| Q47135954 | Degeneration of the osteocyte network in the C57BL/6 mouse model of aging |
| Q47105930 | Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes |
| Q38832148 | Deletion of a Distal RANKL Gene Enhancer Delays Progression of Atherosclerotic Plaque Calcification in Hypercholesterolemic Mice. |
| Q34228323 | Deletion of a single β-catenin allele in osteocytes abolishes the bone anabolic response to loading |
| Q36808470 | Deletion of the Distal Tnfsf11 RL-D2 Enhancer That Contributes to PTH-Mediated RANKL Expression in Osteoblast Lineage Cells Results in a High Bone Mass Phenotype in Mice |
| Q37970800 | Denosumab for the management of bone disease in patients with solid tumors |
| Q35452966 | Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failure |
| Q54265115 | Dentine matrix protein 1 (DMP-1) is a marker of bone-forming tumours. |
| Q36629738 | Development of the endochondral skeleton |
| Q92277418 | Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-κB-NFATc1 signal pathway |
| Q47114199 | Diet and Exercise: a Match Made in Bone |
| Q48204635 | Direct cell-cell contact between mature osteoblasts and osteoclasts dynamically controls their functions in vivo |
| Q39010800 | Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways. |
| Q36699646 | Disruption of claudin-18 diminishes ovariectomy-induced bone loss in mice |
| Q41853542 | Diverse osteoclastogenesis of bone marrow from mandible versus long bone |
| Q37631418 | Dmp1 Promoter-Driven Diphtheria Toxin Receptor Transgene Expression Directs Unforeseen Effects in Multiple Tissues |
| Q36055881 | Do epigenetic marks govern bone mass and homeostasis? |
| Q30557138 | Dysapoptosis of osteoblasts and osteocytes increases cancellous bone formation but exaggerates cortical porosity with age. |
| Q27345068 | Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice |
| Q38814167 | E11/Podoplanin Protein Stabilization Through Inhibition of the Proteasome Promotes Osteocyte Differentiation in Murine in Vitro Models |
| Q35805977 | ERK1 and ERK2 regulate chondrocyte terminal differentiation during endochondral bone formation |
| Q48138766 | Early bone tissue aging in human auditory ossicles is accompanied by excessive hypermineralization, osteocyte death and micropetrosis |
| Q92158664 | Effect of TNF-α-Induced Sclerostin on Osteocytes during Orthodontic Tooth Movement |
| Q33896735 | Effect of age on regulation of human osteoclast differentiation |
| Q36849984 | Effect of zoledronate on the responses of osteocytes to acute parathyroid hormone. |
| Q91386375 | Effective CRISPR interference of an endogenous gene via a single transgene in mice |
| Q35864023 | Effects of Deletion of ERα in Osteoblast-Lineage Cells on Bone Mass and Adaptation to Mechanical Loading Differ in Female and Male Mice |
| Q24631082 | Effects of PTH on osteocyte function |
| Q47963128 | Effects of Sex and Notch Signaling on the Osteocyte Cell Pool |
| Q37624806 | Effects of bioactive lipids and lipoproteins on bone. |
| Q45875296 | Effects of hypothalamic leptin gene therapy on osteopetrosis in leptin-deficient mice |
| Q91404818 | Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes |
| Q33723186 | Elevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV transgenic rats |
| Q91659143 | Elimination of senescent osteoclast progenitors has no effect on the age-associated loss of bone mass in mice |
| Q21131222 | Emerging Functions of RANKL in Lymphoid Tissues |
| Q35755106 | Endogenous Glucocorticoids and Bone. |
| Q90718787 | Endoplasmic reticulum stress is induced in growth plate hypertrophic chondrocytes in G610C mouse model of osteogenesis imperfecta |
| Q92767392 | Endothelial proteolytic activity and interaction with non-resorbing osteoclasts mediate bone elongation |
| Q57265483 | EphrinB2 Signalling in Osteoblast Differentiation, Bone Formation and Endochondral Ossification |
| Q37289187 | Epidermal growth factor receptor (EGFR) signaling regulates epiphyseal cartilage development through β-catenin-dependent and -independent pathways |
| Q53645929 | Establishment of optimized in vitro assay methods for evaluating osteocyte functions. |
| Q38661460 | Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells |
| Q36179747 | Estrogen and the skeleton |
| Q37621495 | Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice |
| Q36497298 | Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrual |
| Q34543980 | Estrogens and Androgens in Skeletal Physiology and Pathophysiology |
| Q35287635 | Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association |
| Q30009390 | Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss |
| Q55247652 | Evidence for Ongoing Modeling-Based Bone Formation in Human Femoral Head Trabeculae via Forming Minimodeling Structures: A Study in Patients with Fractures and Arthritis. |
| Q35143361 | Evidence for the role of connexin 43-mediated intercellular communication in the process of intracortical bone resorption via osteocytic osteolysis |
| Q38307446 | Evolutionary physiology of bone: bone metabolism in changing environments. |
| Q33585182 | Excessive dietary intake of vitamin A reduces skull bone thickness in mice |
| Q38726181 | Experimental studies of bone mechanoadaptation: bridging in vitro and in vivo studies with multiscale systems |
| Q61446362 | Extracellular vesicles in bone: "dogrobbers" in the "eternal battle field" |
| Q46943837 | FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2. |
| Q35253119 | FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation |
| Q36280893 | FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC. |
| Q37052939 | FOXOs attenuate bone formation by suppressing Wnt signaling. |
| Q38365059 | Fate of growth plate hypertrophic chondrocytes: death or lineage extension? |
| Q35779219 | Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. |
| Q92426976 | Flrt2 is involved in fine-tuning of osteoclast multinucleation |
| Q92621353 | Focal adhesion protein Kindlin-2 regulates bone homeostasis in mice |
| Q36617127 | For whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases |
| Q90451142 | Friend or Foe? Essential Roles of Osteoclast in Maintaining Skeletal Health |
| Q47668279 | From Osteoimmunology to Osteomicrobiology: How the Microbiota and the Immune System Regulate Bone. |
| Q54289536 | From the bench to exploration medicine: NASA life sciences translational research for human exploration and habitation missions. |
| Q41907618 | Functional heterogeneity of osteocytes in FGF23 production: the possible involvement of DMP1 as a direct negative regulator. |
| Q27002647 | Functions of the osteocyte network in the regulation of bone mass |
| Q38027020 | Genetics of osteoporosis from genome-wide association studies: advances and challenges |
| Q37714895 | Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis |
| Q51093091 | Glucocorticoid-Induced Osteoporosis. |
| Q36157622 | Glucocorticoid-induced osteoporosis and osteonecrosis |
| Q38195432 | Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives. |
| Q38266799 | Glucocorticoid-induced osteoporosis: who to treat with what agent? |
| Q35126180 | HDAC5 controls MEF2C-driven sclerostin expression in osteocytes |
| Q50020268 | HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice |
| Q36489227 | Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption |
| Q38848655 | Hajdu-Cheney Syndrome, a Disease Associated with NOTCH2 Mutations |
| Q48303279 | Hallmarks of Bone Metastasis |
| Q37234928 | Haploinsufficiency of osterix in chondrocytes impairs skeletal growth in mice |
| Q100752651 | Hindlimb unloading causes regional loading-dependent changes in osteocyte inflammatory cytokines that are modulated by exogenous irisin treatment |
| Q50469317 | Histological evidence that metformin reverses the adverse effects of diabetes on orthodontic tooth movement in rats. |
| Q36442972 | Histone deacetylase 3 is required for maintenance of bone mass during aging |
| Q36742145 | Histone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (Phlpp)1 expression in chondrocytes to suppress Akt signaling and matrix secretion |
| Q52715750 | Histone demethylase LSD1 regulates bone mass by controlling WNT7B and BMP2 signaling in osteoblasts. |
| Q27027402 | Historically significant events in the discovery of RANK/RANKL/OPG |
| Q49912580 | Host defense against oral microbiota by bone-damaging T cells. |
| Q90397024 | How Physical Activity across the Lifespan Can Reduce the Impact of Bone Ageing: A Literature Review |
| Q38968738 | How rare bone diseases have informed our knowledge of complex diseases |
| Q38794651 | Hypomorphic conditional deletion of E11/Podoplanin reveals a role in osteocyte dendrite elongation |
| Q35633235 | Hypothesis: Coupling between Resorption and Formation in Cancellous bone Remodeling is a Mechanically Controlled Event |
| Q54293545 | IL-1β and compressive forces lead to a significant induction of RANKL-expression in primary human cementoblasts. |
| Q89761248 | IL-33/IL-31 Axis in Osteoporosis |
| Q39027493 | IL-6 alters osteocyte signaling toward osteoblasts but not osteoclasts |
| Q92686848 | IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis |
| Q37621816 | Identification of Senescent Cells in the Bone Microenvironment |
| Q89668133 | IgSF11 regulates osteoclast differentiation through association with the scaffold protein PSD-95 |
| Q40958715 | Immediate effects of retinoic acid on gene expression in primary murine osteoblasts |
| Q88540268 | Impact of the Autonomic Nervous System on the Skeleton |
| Q35221512 | Impaired bone homeostasis in amyotrophic lateral sclerosis mice with muscle atrophy. |
| Q26858876 | In vitro and in vivo approaches to study osteocyte biology |
| Q37087683 | Increased bone mass in mice lacking the adipokine apelin |
| Q36696225 | Increased mandibular condylar growth in mice with estrogen receptor beta deficiency |
| Q37018548 | Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton |
| Q42134971 | Inflammation and bone destruction in arthritis: synergistic activity of immune and mesenchymal cells in joints |
| Q87400126 | Inflammatory factors in the circulation of patients with active rheumatoid arthritis stimulate osteoclastogenesis via endogenous cytokine production by osteoblasts |
| Q36216958 | Inflammatory focal bone destruction in femoral heads with end-stage haemophilic arthropathy: a study on clinic samples with micro-CT and histological analyses |
| Q39324315 | Inhibition of mechanical stress-induced NF-κB promotes bone formation |
| Q35905296 | Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading |
| Q42248557 | Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone |
| Q27316867 | Integrin-Alpha IIb Identifies Murine Lymph Node Lymphatic Endothelial Cells Responsive to RANKL |
| Q37994636 | Intercellular cross-talk among bone cells: new factors and pathways. |
| Q88220668 | Interleukin-1-induced acute bone resorption facilitates the secretion of fibroblast growth factor 23 into the circulation |
| Q58784782 | Involvement of Osteocytes in the Action of Toxin |
| Q38004958 | Is psoriatic arthritis a result of abnormalities in acquired or innate immunity? |
| Q31128487 | Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling |
| Q37981265 | Leukemia inhibitory factor: a paracrine mediator of bone metabolism. |
| Q38716121 | Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss |
| Q36255236 | Loss of menin in osteoblast lineage affects osteocyte-osteoclast crosstalk causing osteoporosis |
| Q36785422 | Low bone mass and changes in the osteocyte network in mice lacking autophagy in the osteoblast lineage |
| Q52699543 | MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production. |
| Q33835628 | Maintenance of Bone Homeostasis by DLL1-Mediated Notch Signaling |
| Q104466224 | Making and Shaping Endochondral and Intramembranous Bones |
| Q48187280 | Mammalian target of rapamycin as a therapeutic target in osteoporosis |
| Q38033444 | Management of glucocorticoid-induced osteoporosis. |
| Q58582775 | Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups |
| Q36019769 | Mechanical regulation of signaling pathways in bone |
| Q36109949 | Mechanical vibration inhibits osteoclast formation by reducing DC-STAMP receptor expression in osteoclast precursor cells |
| Q90401265 | Mechanically-Loaded Breast Cancer Cells Modify Osteocyte Mechanosensitivity by Secreting Factors That Increase Osteocyte Dendrite Formation and Downstream Resorption |
| Q26798296 | Mechanism and Treatment Strategy of Osteoporosis after Transplantation |
| Q52805840 | Mechanisms of bone response to injury. |
| Q36994689 | Membrane trafficking in osteoblasts and osteoclasts: new avenues for understanding and treating skeletal diseases |
| Q64960178 | Mesenchymal Stromal Cell-Seeded Biomimetic Scaffolds as a Factory of Soluble RANKL in Rankl-Deficient Osteopetrosis. |
| Q34246045 | Mice Deficient in NF-κB p50 and p52 or RANK Have Defective Growth Plate Formation and Post-natal Dwarfism. |
| Q35259448 | Microgravity control of autophagy modulates osteoclastogenesis. |
| Q35054970 | Minireview: nuclear receptor regulation of osteoclast and bone remodeling |
| Q37034768 | Mitogen-inducible gene-6 partly mediates the inhibitory effects of prenatal dexamethasone exposure on endochondral ossification in long bones of fetal rats |
| Q26851553 | Modulation of osteoclast differentiation and bone resorption by Rho GTPases |
| Q38721980 | Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy. |
| Q38249864 | Molecular and cellular basis of bone resorption |
| Q90047097 | Molecular determinants for the polarization of macrophage and osteoclast |
| Q98465934 | Molecular mechanisms and clinical management of cancer bone metastasis |
| Q55261693 | Molecular mechanisms of glucocorticoids on skeleton and bone regeneration after fracture. |
| Q38113518 | Molecular mechanisms of osteoblast/osteocyte regulation by connexin43. |
| Q38074961 | Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts |
| Q37110385 | Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone. |
| Q89208054 | Mouse Cre Models for the Study of Bone Diseases |
| Q37673482 | Mouse models for the evaluation of osteocyte functions |
| Q38155200 | Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis |
| Q38070410 | Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond |
| Q39014215 | Murine Rankl-/- Mesenchymal Stromal Cells Display an Osteogenic Differentiation Defect Improved by a RANKL-Expressing Lentiviral Vector |
| Q38557126 | Muscle-Bone Crosstalk in Amyotrophic Lateral Sclerosis |
| Q42906705 | Mutual enhancement of differentiation of osteoblasts and osteocytes occurs through direct cell-cell contact |
| Q36595304 | Myelopoiesis is regulated by osteocytes through Gsα-dependent signaling |
| Q38705141 | Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication |
| Q27007096 | NSAID therapy effects on healing of bone, tendon, and the enthesis |
| Q38052462 | New developments in osteoimmunology |
| Q37987556 | New regulation mechanisms of osteoclast differentiation |
| Q38169910 | Nitric oxide signaling in mechanical adaptation of bone |
| Q28590415 | Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling |
| Q27324936 | Novel approaches for two and three dimensional multiplexed imaging of osteocytes |
| Q26853017 | Nuclear receptors in bone physiology and diseases |
| Q35899482 | Nur77 prevents excessive osteoclastogenesis by inducing ubiquitin ligase Cbl-b to mediate NFATc1 self-limitation. |
| Q50701558 | OA10 is a novel p38alpha mitogen-activated protein kinase inhibitor that suppresses osteoclast differentiation and bone resorption. |
| Q36246080 | OsteoRheumatology: a new discipline? |
| Q36542861 | Osteoblast lineage-specific effects of notch activation in the skeleton |
| Q36040583 | Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass |
| Q38289071 | Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. |
| Q39162234 | Osteoblasts subjected to mechanical strain inhibit osteoclastic differentiation and bone resorption in a co-culture system |
| Q36568536 | Osteoclast fusion and regulation by RANKL-dependent and independent factors |
| Q36580426 | Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation |
| Q36949734 | Osteoclasts and CD8 T cells form a negative feedback loop that contributes to homeostasis of both the skeletal and immune systems |
| Q64236844 | Osteoclasts in the Inflammatory Arthritis: Implications for Pathologic Osteolysis |
| Q35755039 | Osteoclasts: New Insights |
| Q33846076 | Osteocyte Apoptosis Caused by Hindlimb Unloading is Required to Trigger Osteocyte RANKL Production and Subsequent Resorption of Cortical and Trabecular Bone in Mice Femurs |
| Q38671237 | Osteocyte Mechanobiology |
| Q36253514 | Osteocyte RANKL: new insights into the control of bone remodeling |
| Q64971630 | Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice. |
| Q36759428 | Osteocyte apoptosis |
| Q33803842 | Osteocyte apoptosis is required for production of osteoclastogenic signals following bone fatigue in vivo. |
| Q38230277 | Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? |
| Q36514172 | Osteocyte control of osteoclastogenesis |
| Q41085034 | Osteocyte isolation and culture methods |
| Q45898154 | Osteocyte lacunar density and area in newly formed bone of the augmented sinus. |
| Q34328711 | Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading |
| Q49847220 | Osteocyte regulation of bone and blood |
| Q37981072 | Osteocyte regulation of bone mineral: a little give and take. |
| Q41459925 | Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression. |
| Q36005495 | Osteocyte signaling in bone |
| Q35700825 | Osteocyte specific responses to soluble and mechanical stimuli in a stem cell derived culture model. |
| Q34017216 | Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency |
| Q35032099 | Osteocyte-derived insulin-like growth factor I is not essential for the bone repletion response in mice |
| Q37626024 | Osteocyte-driven bone remodeling |
| Q36357606 | Osteocytes and Skeletal Pathophysiology |
| Q87264632 | Osteocytes and chondrocytes embedded in bone matrix control bone remodelling |
| Q48153017 | Osteocytes play an important role in experimental periodontitis in healthy and diabetic mice through expression of RANKL. |
| Q39998421 | Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis |
| Q36759496 | Osteocytes remove and replace perilacunar mineral during reproductive cycles |
| Q85040085 | Osteocytes, RANKL and bone loss |
| Q28267634 | Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone |
| Q37958204 | Osteocytes: central conductors of bone biology in normal and pathological conditions |
| Q27022407 | Osteocytes: master orchestrators of bone |
| Q37404925 | Osteocytic osteolysis: time for a second look? |
| Q55517542 | Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin. |
| Q38845640 | Osteocytic signalling pathways as therapeutic targets for bone fragility |
| Q88248494 | Osteoimmunology |
| Q38109578 | Osteoimmunology and bone homeostasis: relevance to spondyloarthritis |
| Q92405052 | Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms |
| Q47944184 | Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. |
| Q92668034 | Osteoimmunology: evolving concepts in bone-immune interactions in health and disease |
| Q38216026 | Osteoimmunology: oncostatin M as a pleiotropic regulator of bone formation and resorption in health and disease |
| Q38116019 | Osteoimmunology: the expanding role of immunoreceptors in osteoclasts and bone remodeling |
| Q55056509 | Osteopetrosis rescue upon RANKL administration to Rankl(-/-) mice: a new therapy for human RANKL-dependent ARO. |
| Q41791623 | Osteoprotection by semaphorin 3A. |
| Q38659295 | Overcoming physical constraints in bone engineering: 'the importance of being vascularized'. |
| Q38183791 | Overview of skeletal development |
| Q34356431 | Oxytocin and bone |
| Q36012130 | P2X7R-Panx1 Complex Impairs Bone Mechanosignaling under High Glucose Levels Associated with Type-1 Diabetes |
| Q90289155 | PGC-1α Controls Skeletal Stem Cell Fate and Bone-Fat Balance in Osteoporosis and Skeletal Aging by Inducing TAZ |
| Q37221508 | PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption. |
| Q37096266 | Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it |
| Q27308118 | Parathyroid Hormone Induces Bone Cell Motility and Loss of Mature Osteocyte Phenotype through L-Calcium Channel Dependent and Independent Mechanisms |
| Q57151535 | Parathyroid Hormone Signaling in Osteocytes |
| Q92854752 | Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells |
| Q58095951 | Parathyroid hormone (1-34) and its analogs differentially modulate osteoblastic RANKL expression via PKA/PP1/PP2A and SIK2/SIK3-CRTC3 signaling |
| Q37012357 | Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. |
| Q42511931 | Parathyroid hormone inhibits Notch signaling in osteoblasts and osteocytes |
| Q33901231 | Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes |
| Q33609126 | Parathyroid hormone: anabolic and catabolic actions on the skeleton |
| Q37305810 | Pathogenesis of age-related bone loss in humans |
| Q89860655 | Pathological Crosstalk between Metastatic Breast Cancer Cells and the Bone Microenvironment |
| Q33814335 | Periosteal PTHrP regulates cortical bone modeling during linear growth in mice |
| Q35027916 | Periostin deficiency increases bone damage and impairs injury response to fatigue loading in adult mice |
| Q64241093 | Physical Activity and Bone Health: What Is the Role of Immune System? A Narrative Review of the Third Way |
| Q92718272 | Physicochemical Niche Conditions and Mechanosensing by Osteocytes and Myocytes |
| Q38867785 | Physiological and pathophysiological bone turnover - role of the immune system |
| Q34369482 | Physiological functions of osteoblast lineage and T cell-derived RANKL in bone homeostasis |
| Q35953079 | Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-κB Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts |
| Q33559842 | Postnatal Calvarial Skeletal Stem Cells Expressing PRX1 Reside Exclusively in the Calvarial Sutures and Are Required for Bone Regeneration |
| Q39589743 | Profilin1 regulates sternum development and endochondral bone formation |
| Q55423545 | Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts. |
| Q33744573 | Quiescent Bone Lining Cells Are a Major Source of Osteoblasts During Adulthood |
| Q48039377 | RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice |
| Q89666841 | RANKL biology: bone metabolism, the immune system, and beyond |
| Q54228752 | RANKL blockade prevents and treats aggressive osteosarcomas. |
| Q36898545 | RANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare disease |
| Q52684327 | RANKL deletion in periodontal ligament and bone lining cells blocks orthodontic tooth movement. |
| Q53487298 | RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. |
| Q42409559 | RANKL expression in periodontal disease: where does RANKL come from? |
| Q59806646 | RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation |
| Q36246148 | RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis |
| Q38306944 | RANKL/OPG; Critical role in bone physiology. |
| Q89967663 | RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies |
| Q90999941 | Rapid bone loss occurs as early as 2 days after complete spinal cord transection in young adult rats |
| Q92460351 | Rapid fabrication of vascularized and innervated cell-laden bone models with biomimetic intrafibrillar collagen mineralization |
| Q50215136 | Recent advances in osteoclast biology. |
| Q26863480 | Recent progress in osteocyte research |
| Q36216058 | Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss |
| Q59095964 | Receptor becomes a ligand to control bone remodelling |
| Q38104374 | Recombinant hormones in osteoporosis |
| Q48528045 | Regulation of Bone Remodeling by Parathyroid Hormone |
| Q64069924 | Regulation of Osteoclast Differentiation and Skeletal Maintenance by Histone Deacetylases |
| Q64933738 | Regulation of Skeletal Homeostasis. |
| Q38681571 | Regulation of bone metabolism by Wnt signals |
| Q38183261 | Regulatory mechanisms of RANKL presentation to osteoclast precursors |
| Q35107089 | Repair of microdamage in osteonal cortical bone adjacent to bone screw |
| Q46470367 | Report of the CCFA pediatric bone, growth and muscle health workshop, New York City, November 11-12, 2011, with updates |
| Q36855971 | Retinoic acid-induced premature osteoblast-to-preosteocyte transitioning has multiple effects on calvarial development |
| Q27316361 | Rib fractures and death from deletion of osteoblast βcatenin in adult mice is rescued by corticosteroids |
| Q35916106 | Role of DNA methylation in the regulation of the RANKL-OPG system in human bone |
| Q37673466 | Role of Osteocyte-derived Insulin-Like Growth Factor I in Developmental Growth, Modeling, Remodeling, and Regeneration of the Bone. |
| Q26992195 | Role of osteocytes in multiple myeloma bone disease |
| Q89305255 | Role of pannexin 1 channels in load-induced skeletal response |
| Q36585836 | Role of paraoxonase-1 in bone anabolic effects of parathyroid hormone in hyperlipidemic mice |
| Q38056632 | Roles of Wnt signals in bone resorption during physiological and pathological states. |
| Q35949809 | Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation |
| Q34075583 | SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model |
| Q42371007 | SHP2 Regulates the Osteogenic Fate of Growth Plate Hypertrophic Chondrocytes |
| Q37360148 | SIKs control osteocyte responses to parathyroid hormone |
| Q37660607 | SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts |
| Q38986059 | SaOS2 Osteosarcoma cells as an in vitro model for studying the transition of human osteoblasts to osteocytes. |
| Q33825376 | Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading |
| Q53507211 | Sclerostin antibody preserves the morphology and structure of osteocytes and blocks the severe skeletal deterioration after motor-complete spinal cord injury in rats. |
| Q48233828 | Sclerostin expression in bone tumours and tumour-like lesions. |
| Q31032805 | Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway |
| Q43751384 | Selective glucocorticoid receptor modulation maintains bone mineral density in mice |
| Q91854213 | Sensory innervation in porous endplates by Netrin-1 from osteoclasts mediates PGE2-induced spinal hypersensitivity in mice |
| Q42590314 | Serotonin: a novel bone mass controller may have implications for alveolar bone |
| Q36201481 | Serum sclerostin increases in healthy adult men during bed rest. |
| Q34437537 | Sex steroid actions in male bone |
| Q36951811 | Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics |
| Q38192647 | Shifting paradigms on the role of connexin43 in the skeletal response to mechanical load |
| Q37354085 | Skeletal metastasis: treatments, mouse models, and the Wnt signaling |
| Q40668097 | Smad1/5 and Smad4 expression are important for osteoclast differentiation |
| Q37310243 | Smad4 controls bone homeostasis through regulation of osteoblast/osteocyte viability |
| Q61135621 | Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss |
| Q97643643 | Soluble RANKL is physiologically dispensable but accelerates tumour metastasis to bone |
| Q47559021 | Solute Transport in the Bone Lacunar-Canalicular System (LCS). |
| Q34547308 | Spinal Cord Injury and Osteoporosis: Causes, Mechanisms, and Rehabilitation Strategies |
| Q34182834 | Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data |
| Q36793504 | Steroids and osteoporosis: the quest for mechanisms |
| Q36395303 | Stimulation of Osteogenesis in Bone Defects Implanted with Biodegradable Hydroxyapatite Composed of Rod-Shaped Particles under Mechanical Unloading |
| Q83228035 | Stimulation of Piezo1 by mechanical signals promotes bone anabolism |
| Q36636031 | Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-κB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity |
| Q38943616 | Strontium content and collagen-I coating of Magnesium-Zirconia-Strontium implants influence osteogenesis and bone resorption. |
| Q27300809 | Study of Osteoclast Adhesion to Cortical Bone Surfaces: A Correlative Microscopy Approach for Concomitant Imaging of Cellular Dynamics and Surface Modifications |
| Q90366914 | Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain |
| Q64891393 | Subchondral bone remodelling in osteoarthritis. |
| Q35286818 | Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone |
| Q36929011 | Suppression of autophagy in osteocytes mimics skeletal aging |
| Q51499839 | Supramolecular assemblies of histidinylated β-cyclodextrin for enhanced oligopeptide delivery into osteoclast precursors. |
| Q48047171 | Surface microtopography modulates sealing zone development in osteoclasts cultured on bone |
| Q92298046 | Systemic Bone Loss After Fracture |
| Q51515623 | Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression. |
| Q30422958 | Systems genetic analysis of osteoblast-lineage cells |
| Q27311542 | T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer |
| Q36984760 | T-Type voltage-sensitive calcium channels mediate mechanically-induced intracellular calcium oscillations in osteocytes by regulating endoplasmic reticulum calcium dynamics. |
| Q93053015 | TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis |
| Q38108518 | Talking among ourselves: paracrine control of bone formation within the osteoblast lineage |
| Q51046195 | Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype. |
| Q38956445 | Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone |
| Q38861119 | Targeting of Mesenchymal Stromal Cells by Cre-Recombinase Transgenes Commonly Used to Target Osteoblast Lineage Cells |
| Q47156108 | Targeting subchondral bone mesenchymal stem cell activities for intrinsic joint repair in osteoarthritis |
| Q34983640 | Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes |
| Q27311269 | The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation |
| Q36649905 | The Dmp1-SOST Transgene Interacts With and Downregulates the Dmp1-Cre Transgene and the Rosa(Notch) Allele |
| Q90040615 | The Effects of Tocotrienol on Bone Peptides in a Rat Model of Osteoporosis Induced by Metabolic Syndrome: The Possible Communication between Bone Cells |
| Q64096227 | The Emerging Role of Osteocytes in Cancer in Bone |
| Q50069952 | The Expanding Life and Functions of Osteogenic Cells: From Simple Bone-Making Cells to Multifunctional Cells and Beyond |
| Q57790452 | The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases |
| Q41140478 | The Microdamage and Expression of Sclerostin in Peri-implant Bone under One-time Shock Force Generated by Impact |
| Q26773017 | The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis |
| Q92358408 | The Osteocyte Transcriptome Is Extensively Dysregulated in Mouse Models of Osteogenesis Imperfecta |
| Q64106454 | The Osteocyte as a Novel Key Player in Understanding Periodontitis Through its Expression of RANKL and Sclerostin: a Review |
| Q98177574 | The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases |
| Q35744006 | The RANKL distal control region is required for the increase in RANKL expression, but not the bone loss, associated with hyperparathyroidism or lactation in adult mice |
| Q64102143 | The RANKL-RANK Axis: A Bone to Thymus Round Trip |
| Q56453532 | The Role of Estrogen Receptor in Bone Cells |
| Q37287589 | The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis |
| Q38747978 | The Role of Osteocytes in Age-Related Bone Loss |
| Q64268866 | The Role of Osteocytes in Inflammatory Bone Loss |
| Q39107516 | The Role of the Osteocyte in Bone and Nonbone Disease |
| Q35860523 | The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro |
| Q88296450 | The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation |
| Q33920055 | The best of both worlds - managing the cancer, saving the bone |
| Q36832631 | The central nervous system (CNS)-independent anti-bone-resorptive activity of muscle contraction and the underlying molecular and cellular signatures |
| Q38200066 | The chondrocytic journey in endochondral bone growth and skeletal dysplasia |
| Q36275737 | The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption |
| Q58085028 | The conundrum of glucocorticoid-induced osteoporosis |
| Q33918020 | The effects of proteasome inhibitors on bone remodeling in multiple myeloma |
| Q38669228 | The effects of tumour necrosis factor-α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes. |
| Q37622533 | The expression of Fn14 via mechanical stress-activated JNK contributes to apoptosis induction in osteoblasts. |
| Q38654266 | The interfacial pH of acidic degradable polymeric biomaterials and its effects on osteoblast behavior |
| Q64949054 | The lateral meningocele syndrome mutation causes marked osteopenia in mice. |
| Q35583735 | The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice |
| Q50651156 | The mineral dissolution function of osteoclasts is dispensable for hypertrophic cartilage degradation during long bone development and growth. |
| Q36553435 | The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis |
| Q36593285 | The multifaceted actions of PTHrP in skeletal metastasis |
| Q27013693 | The multifaceted role of the vasculature in endochondral fracture repair |
| Q38050401 | The multiple facets of glucocorticoid action in rheumatoid arthritis |
| Q37203605 | The osteocyte: an endocrine cell ... and more |
| Q26777912 | The osteocyte: key player in regulating bone turnover |
| Q42002069 | The parathyroid hormone-regulated transcriptome in osteocytes: parallel actions with 1,25-dihydroxyvitamin D3 to oppose gene expression changes during differentiation and to promote mature cell function |
| Q38961342 | The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation. |
| Q35831159 | The regulation of osteoclast differentiation by Wnt signals |
| Q37189204 | The relevance of mouse models for investigating age-related bone loss in humans |
| Q33565236 | The role of DNA methylation in common skeletal disorders |
| Q45222224 | The role of bone marrow-derived cells during the bone healing process in the GFP mouse bone marrow transplantation model. |
| Q37337490 | The role of osteoblasts in bone metastasis |
| Q36941660 | The role of osteoclast differentiation and function in skeletal homeostasis |
| Q34744797 | The role of osteocytes in targeted bone remodeling: a mathematical model |
| Q39248512 | The role of stromal cells in inflammatory bone loss |
| Q38050402 | The skeleton as an endocrine organ |
| Q33675404 | Three-dimensional system enabling the maintenance and directed differentiation of pluripotent stem cells under defined conditions |
| Q36054527 | Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. |
| Q38012387 | Toward mechanical systems biology in bone |
| Q50104779 | Transforming growth factor-β in stem cells and tissue homeostasis |
| Q35453039 | Treatment of immobilization-related hypercalcaemia with denosumab |
| Q58752199 | Treatment options for osteogenesis imperfecta |
| Q89167528 | Tsc1 Regulates the Balance Between Osteoblast and Adipocyte Differentiation Through Autophagy/Notch1/β-Catenin Cascade |
| Q57462447 | Ubiquitin-specific protease USP34 controls osteogenic differentiation and bone formation by regulating BMP2 signaling |
| Q38775640 | Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity |
| Q36521118 | Unique Distal Enhancers Linked to the Mouse Tnfsf11 Gene Direct Tissue-Specific and Inflammation-Induced Expression of RANKL. |
| Q35744492 | Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives |
| Q50093296 | Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity |
| Q58609488 | Use it or lose it to age: A review of bone and muscle communication |
| Q35692597 | Vibration therapy: clinical applications in bone |
| Q37620408 | Vitamin D endocrine system and osteocytes |
| Q34621641 | Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. |
| Q35067782 | Vitamin a is a negative regulator of osteoblast mineralization |
| Q36695575 | Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling |
| Q28285090 | WNT signaling in bone homeostasis and disease: from human mutations to treatments |
| Q91637803 | Wang-Bi Capsule Alleviates the Joint Inflammation and Bone Destruction in Mice with Collagen-Induced Arthritis |
| Q34732774 | Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption |
| Q64075123 | What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss? |
| Q33784662 | Wnt signaling and osteoporosis |
| Q38128460 | Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches |
| Q54528928 | Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. |
| Q64062195 | Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis |
| Q55413820 | Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice. |
| Q95510728 | [Research progress on the cellular and molecular mechanisms of tooth eruption] |
| Q39410557 | microRNA Expression in Rat Apical Periodontitis Bone Lesion |
| Q35860848 | p47phox-Nox2-dependent ROS Signaling Inhibits Early Bone Development in Mice but Protects against Skeletal Aging |
| Q37192084 | α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption |
| Q37381251 | β-catenin activity in late hypertrophic chondrocytes locally orchestrates osteoblastogenesis and osteoclastogenesis |